Propranolol in the management of infantile hemangiomas: Clinical response and predictors

Journal of Cutaneous Medicine and Surgery

Volumn 16, Issue 3, 2012, Pages 169-173

  Balma Mena, Alexandra ^a,b   Chakkittakandiyil, Ajith ^a,b   Weinstein, Miriam ^a,b   Lansang, Perla ^a,b   Ho, Nhung ^a,b   Cammisuli, Salvatore ^a,b   Pope, Elena ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMIQUIMOD; PROPRANOLOL; TIMOLOL;

ARTICLE; BEHAVIOR CHANGE; CAPILLARY HEMANGIOMA; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COLD SENSITIVITY; DIARRHEA; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DYSPNEA; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PHOTOGRAPHY; PREDICTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SIDE EFFECT; SLEEP DISORDER; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR VOLUME; VIRUS INFECTION; VISUAL ANALOG SCALE; VOMITING;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; FEMALE; HEMANGIOMA, CAPILLARY; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASTIC SYNDROMES, HEREDITARY; PHOTOGRAPHY; PROPRANOLOL; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 84864231627     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.2310/7750.2011.10141     Document Type: Article

References (18)

1. Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? A systematic review of the medical literature. Pediatr Dermatol 2008;25:168-73, doi:10.1111/j.1525-1470.2008.00626.x. (Pubitemid 351579596)
2. Boye E, Jinnin M, Olsen BR. Infantile hemangioma: challenges, new insights, and therapeutic promise. J Craniofac Surg 2009;20 Suppl 1:678-84, doi:10.1097/SCS.0b013e318193d6c1.
3. Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009;26:610-4, doi:10.1111/j.1525-1470.2009.00975.x.
4. Pope E, Krafchik BR, Macarthur C, et al. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: a randomized, controlled trial. Pediatrics 2007;119:e1239-47, doi:10.1542/peds.2006-2962. (Pubitemid 46871240)
5. Bennett ML, Fleischer AB Jr, Chamlin SL, Frieden IJ. Oral corticosteroid use is effective for cutaneous hemangiomas: an evidence-based evaluation. Arch Dermatol 2001;137:1208-13. (Pubitemid 32847844)
6. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51, doi:10.1056/NEJMc0708819. (Pubitemid 351831393)
7. Sans V, de la Roque ED, Berge J, et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009;124:e423-31, doi: 10.1542/peds.2008-3458.
8. Zimmermann AP, Wiegand S, Werner JA, Eivazi B. Propranolol therapy for infantile haemangiomas: review of the literature. Int J Pediatr Otorhinolaryngol 2010;74:338-42, doi:10.1016/j.ijporl.2010.01.001.
9. Naouri M, Schill T, Maruani A, et al. Successful treatment of ulcerated haemangioma with propranolol. J Eur Acad Dermatol Venereol 2010;24:1109-12.
10. Leboulanger N, Fayoux P, Teissier N, et al. Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma: a preliminary retrospective study of French experience. Int J Pediatr Otorhinolaryngol 2010;74:1254-7.
11. Fulkerson DH, Agim NG, Al-Shamy G, et al. Emergent medical and surgical management of mediastinal infantile hemangioma with symptomatic spinal cord compression: case report and literature review. Childs Nerv Syst 2010;26:1799-805.
12. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, et al. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. J Pediatr 2010;157:340-2, doi:10.1016/j.jpeds.2010.04.003.
13. Manunza F, Syed S, Laguda B, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 2010;162:466-8, doi:10.1111/j.1365-2133.2009.09597.x.
14. Theletsane T, Redfern A, Raynham O, et al. Life-threatening infantile haemangioma: a dramatic response to propranolol. J Eur Acad Dermatol Venereol 2009;23:1465-6, doi:10.1111/j.1468-3083.2009.03261.x.
15. Buckmiller L, Dyamenahalli U, Richter GT. Propranolol for airway hemangiomas: case report of novel treatment. Laryngoscope 2009;119:2051-4, doi:10.1002/lary.20633.
16. Holland KE, Frieden IJ, Frommelt PC, et al. Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010;146:775-8, doi:10.1001/archdermatol.2010.158.
17. Pavlakovic H, Kietz S, Lauerer P, et al. Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics 2010;126:e1589-93, doi:10.1542/peds.2010-0077.
18. Siegfried EC, Keenan WJ, Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 2008;359:2846, author reply 2847, doi:10.1056/NEJMc086443.